BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31762133)

  • 1. Complications of cardiac implantable electronic device placement in public and private hospitals.
    Ganesan AN; Moore K; Horton D; Heddle W; McGavigan AD; Hossain S; Ali A; Hariharaputhiran S; Ranasinghe I
    Intern Med J; 2020 Oct; 50(10):1207-1216. PubMed ID: 31762133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in Acute Complications of Cardiac Implantable Electronic Devices: Implications for Patient Safety.
    Moore K; Ganesan A; Labrosciano C; Heddle W; McGavigan A; Hossain S; Horton D; Hariharaputhiran S; Ranasinghe I
    J Am Heart Assoc; 2019 Jan; 8(2):e010869. PubMed ID: 30648465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with cardiac implantable electronic device-related infections, New South Wales, 2016-21: a retrospective cohort study.
    Shawon MSR; Sotade OT; Li J; Hill MD; Strachan L; Challis G; King K; Ooi SY; Jorm L
    Med J Aust; 2024 Jun; 220(10):510-516. PubMed ID: 38711337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very early discharge after cardiac implantable electronic device implantations: is this the future?
    Ohlow MA; Awada H; Laubscher M; Geller JC; Brunelli M
    J Interv Card Electrophysiol; 2021 Mar; 60(2):231-237. PubMed ID: 32239387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation: A Cohort Study.
    Ranasinghe I; Labrosciano C; Horton D; Ganesan A; Curtis JP; Krumholz HM; McGavigan A; Hossain S; Air T; Hariharaputhiran S
    Ann Intern Med; 2019 Sep; 171(5):309-317. PubMed ID: 31357210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.
    Demir GG; Guler GB; Guler E; Güneş H; Kizilirmak F; Karaca İO; Omaygenç MO; Çakal B; Olgun E; Savur U; Ibisoglu E; Barutçu I; Kiliçaslan F
    Acta Cardiol; 2017 Feb; 72(1):47-52. PubMed ID: 28597740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.
    Kirkfeldt RE; Johansen JB; Nohr EA; Jørgensen OD; Nielsen JC
    Eur Heart J; 2014 May; 35(18):1186-94. PubMed ID: 24347317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac implantable electronic device placement following alcohol septal ablation for hypertrophic cardiomyopathy in the United States.
    Lam MC; Naidu SS; Kolte D; Kennedy K; Feldman DN; Chu AF; Abbott JD; Gordon P; Aronow HD
    J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2712-2719. PubMed ID: 32671899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Cardiovascular Implantable Electronic Device Insertion Between 1988 and 2018 in Olmsted County.
    Vaidya VR; Asirvatham R; Kowlgi GN; Dai MY; Cochuyt JJ; Hodge DO; Deshmukh AJ; Cha YM
    JACC Clin Electrophysiol; 2022 Jan; 8(1):88-100. PubMed ID: 34454890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.
    Clémenty N; Carion PL; Léotoing L; Lamarsalle L; Wilquin-Bequet F; Brown B; Verhees KJP; Fernandes J; Deharo JC
    Europace; 2018 Dec; 20(12):1974-1980. PubMed ID: 29672690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
    Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018).
    Olsen T; Jørgensen OD; Nielsen JC; Thøgersen AM; Philbert BT; Johansen JB
    Eur Heart J; 2019 Jun; 40(23):1862-1869. PubMed ID: 31155647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta-analysis.
    Rattanawong P; Kewcharoen J; Mekraksakit P; Mekritthikrai R; Prasitlumkum N; Vutthikraivit W; Putthapiban P; Dworkin J
    J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1053-1065. PubMed ID: 30938929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-hospital complications after implantation of cardiac implantable electronic devices: Analysis of a national inpatient database in Japan.
    Shakya S; Matsui H; Fushimi K; Yasunaga H
    J Cardiol; 2017 Nov; 70(5):405-410. PubMed ID: 28434707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in patient characteristics, clinical practice and outcomes of cardiac implantable electric device therapy between Japan and the USA: a cross-sectional study using data from nationally representative administrative databases.
    Tonegawa-Kuji R; Inoue YY; Nakai M; Kanaoka K; Sumita Y; Miyazaki Y; Wakamiya A; Shimamoto K; Ueda N; Nakajima K; Wada M; Kamakura T; Yamagata K; Ishibashi K; Miyamoto K; Nagase S; Aiba T; Miyamoto Y; Iwanaga Y; Kusano K
    BMJ Open; 2023 Jan; 13(1):e068124. PubMed ID: 36639209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in Cardiac electronic device implantation: Outcomes from an Australian multi-centre clinical quality registry.
    Eccleston D; Cehic D; Young G; Lin T; Pavia S; Chowdhury EK; Reid C; Liew D; King B; Tan I; Phillips K; O'Donnell D;
    Int J Cardiol Heart Vasc; 2021 Aug; 35():100828. PubMed ID: 34235244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilisation and safety of catheter ablation of atrial fibrillation in public and private sector hospitals.
    Ngo L; Ali A; Ganesan A; Woodman RJ; Adams R; Ranasinghe I
    BMC Health Serv Res; 2021 Aug; 21(1):883. PubMed ID: 34454482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Implantable Electronic Devices: Reoperations and the Competing Risk of Death.
    Gillam MH; Pratt NL; Inacio MCS; Shakib S; Caughey GE; Sanders P; Lau DH; Roughead EE
    Heart Lung Circ; 2022 Apr; 31(4):537-543. PubMed ID: 34674955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year trends in cardiac implantable electronic devices in New Zealand: a national data linkage study (ANZACS-QI 51).
    Foo FS; Stiles MK; Lee M; Looi KL; Clare GC; Webber M; Boddington D; Jackson R; Poppe KK; Kerr AJ
    Intern Med J; 2022 Apr; 52(4):614-622. PubMed ID: 33070422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.